Aromatase inhibitors in the treatment of advanced breast cancer

This publication has 37 references indexed in Scilit:

• Could aminoglutethimide replace adrenalectomy?
  Breast Cancer Research and Treatment, 1985
• 4-HYDROXYANDROSTENEDIONE IN TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER
  The Lancet, 1984
• Endocrine Changes Associated with Relapse in Advanced Breast Cancer Patients on Aminoglutethimide Therapy
  Journal of Clinical Endocrinology & Metabolism, 1984
• Inhibition of Estrogen Biosynthesis and Regression of Mammary Tumors by Aromatase Inhibitors
  Published by Springer Nature ,1982
• Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo
  Steroids, 1981
• Inhibition of Peripheral Aromatization of Androstenedione to Estrone in Postmenopausal Women with Breast Cancer Using Δ¹Testololactone*
  Journal of Clinical Endocrinology & Metabolism, 1979
• Stereoselective Inhibition of Aromatase by Enantiomers of Aminoglutethimide*
  Endocrinology, 1979
• The Effect of an Aromatase Inhibitor, 4-Hydroxy-4-Androstene- 3,17-Dione, On Estrogen-Dependent Processes in Reproduction and Breast Cancer¹¹
  Endocrinology, 1977
• Preliminary trial of aminoglutethimide in breast cancer
  Cancer, 1973
• Source of Estrogen Production in Postmenopausal Women1
  Journal of Clinical Endocrinology & Metabolism, 1973